Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 10/16/01 → 2/28/03 |
Funding
- DuPont Merck Pharmaceutical Company: $3,000.00
Phase III Study to Assess the Safety and Efficacy of DPC 083 Versus Nelfinavir, Each in Combination with Combivir in Antiretroviral-Naive HIV-1 Infected Subjects
- Greenberg, Richard (PI)